NM_000748.3(CHRNB2):c.373G>T (p.Gly125Cys) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 12, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002292103.2

Allele description [Variation Report for NM_000748.3(CHRNB2):c.373G>T (p.Gly125Cys)]

NM_000748.3(CHRNB2):c.373G>T (p.Gly125Cys)

Gene:

CHRNB2:cholinergic receptor nicotinic beta 2 subunit [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1q21.3

Genomic location:

Preferred name:

NM_000748.3(CHRNB2):c.373G>T (p.Gly125Cys)

HGVS:

NC_000001.11:g.154571196G>T
NG_008027.1:g.8416G>T
NM_000748.3:c.373G>TMANE SELECT
NP_000739.1:p.Gly125Cys
NC_000001.10:g.154543672G>T
NM_000748.2:c.373G>T

Protein change:

G125C

Molecular consequence:

NM_000748.3:c.373G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: CN517202

Recent activity

Clear Turn Off Turn On

Angelica yanyuanensis voucher 20160647(KUN) internal transcribed spacer 1, parti...
Angelica yanyuanensis voucher 20160647(KUN) internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequence
gi|1488152648|gb|MK036627.1|

Nucleotide
PREDICTED: Rattus norvegicus phosphodiesterase 9A (Pde9a), transcript variant X1...
PREDICTED: Rattus norvegicus phosphodiesterase 9A (Pde9a), transcript variant X1, mRNA
gi|2678923603|ref|XM_008772794.4|

Nucleotide
mitochondrial 54S ribosomal protein YmL11 [Saccharomyces cerevisiae S288C]
mitochondrial 54S ribosomal protein YmL11 [Saccharomyces cerevisiae S288C]
gi|6319999|ref|NP_010079.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002584335	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Uncertain significance (Apr 12, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002584335

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Uncertain significance
(Apr 12, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV002584335.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Mar 4, 2023

ClinVar

Relating variation to medicine